Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancers|January 11, 2024
Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized StudiesLine Schmidt Tarpgaard, Stine Brændegaard Winther, Per PfeifferBMJ Open|June 22, 2023
Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocolTobias Freyberg Justesen, Ismail Gögenur, Line Schmidt Tarpgaard, et al.BMC Cancer|January 13, 2017
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancerJesper Andreas Palshof, Estrid Vilma Solyom Høgdall, Tim Svenstrup Poulsen, et al.Pleura and Peritoneum|July 1, 2024
Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)Ingrid Terese Foslund, Sahra Aisha Vinholt von Magius, Alan Patrick Ainsworth, et al.Nature Communications|August 17, 2016
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cellsMads Heilskov Rasmussen, Iben Lyskjær, Rosa Rakownikow Jersie-Christensen, et al.Investigational New Drugs|April 24, 2025
PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancerSusy Shim, Anke Reinacher-Schick, Anna-Lena Kraeft, et al.The Lancet. Gastroenterology & Hepatology|May 1, 2026
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trialLine Schmidt Tarpgaard, Laurids Østergaard Poulsen, Ismail Gögenur, et al.Annals of Surgery|December 18, 2024
Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical TrialIsmail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, et al.Pageof 1